ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $80,000 | +1.3% | 12,200 | 0.0% | 0.02% | +17.6% |
| Q2 2022 | $79,000 | -30.1% | 12,200 | -50.0% | 0.02% | -22.7% |
| Q1 2022 | $113,000 | +79.4% | 24,400 | +100.0% | 0.02% | +100.0% |
| Q4 2021 | $63,000 | -49.6% | 12,200 | 0.0% | 0.01% | -52.2% |
| Q3 2021 | $125,000 | -48.3% | 12,200 | 0.0% | 0.02% | -51.1% |
| Q2 2021 | $242,000 | -28.0% | 12,200 | 0.0% | 0.05% | -33.8% |
| Q1 2021 | $336,000 | +2.4% | 12,200 | 0.0% | 0.07% | -5.3% |
| Q4 2020 | $328,000 | – | 12,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |